Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
6.43
+0.32 (5.24%)
Oct 8, 2025, 12:02 PM EDT - Market open
Immuneering Market Cap
Immuneering has a market cap or net worth of $406.62 million as of October 8, 2025. Its market cap has increased by 327.18% in one year.
Market Cap
406.62M
Enterprise Value
382.37M
1-Year Change
327.18%
Ranking
Category
Stock Price
$6.43
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has increased from $365.84M to $406.62M, an increase of 11.15%. That is a compound annual growth rate of 2.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 386.39M | 465.63% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
| Jul 30, 2021 | 365.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |